Bhavnagri Veer

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
16
Insider Sells Sum
$5.22M

Insider Activity of Bhavnagri Veer

The largest sale of all time was on 2020-08-03 and amounted to 31553 shares of Allogene Therapeutics, Inc. for $1.16M.

Biography of Bhavnagri Veer

No biography is available at this moment.

2023-02-13SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
3,000
0.002%
$6.85$20,550-40.59%
2023-01-17SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
3,000
0.0021%
$7.04$21,120-31.37%
2022-12-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,602
0.0041%
$7.53$42,186-29.66%
2022-03-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
8,849
0.0062%
$7.68$67,962+21.54%
2021-09-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,000
0.0036%
$24.77$123,845-50.78%
2021-08-16SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,000
0.0036%
$21.00$104,994-41.82%
2021-07-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,000
0.0035%
$21.55$107,753-43.76%
2021-06-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,000
0.0038%
$25.32$126,600-38.15%
2021-05-18SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,000
0.0037%
$30.00$150,000-41.11%
2021-05-17SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
5,000
0.0037%
$28.30$141,476-37.8%
2021-04-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
10,000
0.0072%
$32.05$320,517-40.87%
2021-03-15SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
16,623
0.0122%
$37.95$630,798-42.72%
2020-10-06SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
10,000
0.0078%
$40.00$400,000-27.81%
2020-10-01SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
25,000
0.0187%
$36.52$912,913-23.71%
2020-09-01SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
25,000
0.02%
$35.36$883,966-10.4%
2020-08-03SaleAllogene Therapeutics, Inc.
ALLO
General Counsel
31,553
0.0244%
$36.89$1.16M-12.71%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.